Keyphrases
Hemostatic Parameters
100%
Oral Contraceptives
100%
Menstrual Cycle
100%
Drospirenone
100%
Tissue Factor Pathway inhibitor-2 (TFPI-2)
62%
Thrombin Generation
37%
APC Resistance
37%
Oral Contraceptive Use
25%
Prothrombin
25%
Antithrombin
25%
Venous Thromboembolism
25%
Factor VIII (FVIII)
25%
Plasma Parameters
12%
Major Determinants
12%
Plasma Concentration
12%
Limited Information
12%
Coagulation
12%
Coagulation Pathway
12%
Tissue Factor
12%
Healthy Women
12%
Coagulation Parameters
12%
Progestogens
12%
C Protein
12%
Protein C System
12%
C-factor
12%
Free Factor
12%
Women Age
12%
Impaired Function
12%
Anticoagulant Pathways
12%
INIS
proteins
100%
hemostatics
100%
menstrual cycle
100%
tissues
85%
thrombin
42%
risks
28%
length
28%
concentration
28%
plasma
28%
prothrombin
28%
levels
14%
women
14%
information
14%
populations
14%
anticoagulants
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hemostatic Agent
100%
Oral Contraceptive
100%
Drospirenone
100%
Tissue Factor Pathway Inhibitor
50%
Protein C
50%
Thrombin
30%
Protein S
30%
APC
30%
Venous Thromboembolism
20%
Antithrombin
20%
Prothrombin
20%
Anticoagulant Agent
10%
Thromboplastin
10%
Population Study
10%
Procoagulant
10%
Progestin
10%
Neuroscience
Thromboplastin
100%
Drospirenone
100%
Protein C
83%
Thrombin
50%
Protein S
50%
Prothrombin
33%
Antithrombin
33%
Blood Plasma
33%
Antithrombotic
16%
Anticoagulant
16%
Oral Contraceptive Formulations
16%
Progestin
16%
Immunology and Microbiology
Menstrual Cycle
100%
Thromboplastin
100%
Antigen-Presenting Cell
50%
Thrombin
50%
Blood Level
33%
Population Research
16%